TOFACITINIB CITRATE
NDC 0574-1811, Tofacitinib Citrate, tablet, film coated, extended release, from Padagis US LLC.
- Product NDC
- 0574-1811
- Status
- Listed
- Labeler
- Padagis US LLC
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA216001
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0574-1811 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TOFACITINIB CITRATE11 mg/1
Pharmacologic classes
Janus Kinase Inhibitor [EPC]; Janus Kinase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0574-1811-30 | 00574181130 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0574-1811-30) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/df24e90d-4b2c-4f9d-a1d6-fcb1ab00606fNADAC price for package 00574181130
GET /v1/drugs/nadac/00574181130
Use it
Look up 0574-1811 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0574-1811 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0574-1811. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.